BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17981033)

  • 1. Uncovering false positives on a virtual screening search for cruzain inhibitors.
    Malvezzi A; de Rezende L; Izidoro MA; Cezari MH; Juliano L; do Amaral A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):350-4. PubMed ID: 17981033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.
    Huang L; Brinen LS; Ellman JA
    Bioorg Med Chem; 2003 Jan; 11(1):21-9. PubMed ID: 12467703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L.
    Freitas RF; Oprea TI; Montanari CA
    Bioorg Med Chem; 2008 Jan; 16(2):838-53. PubMed ID: 17996450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First quantum mechanics/molecular mechanics studies of the inhibition mechanism of cruzain by peptidyl halomethyl ketones.
    Arafet K; Ferrer S; Moliner V
    Biochemistry; 2015 Jun; 54(21):3381-91. PubMed ID: 25965914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi.
    Trossini GH; Malvezzi A; T-do Amaral A; Rangel-Yagui CO; Izidoro MA; Cezari MH; Juliano L; Chin CM; Menezes CM; Ferreira EI
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):62-7. PubMed ID: 20030510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new class of nonpeptidic inhibitors of cruzain.
    Brak K; Doyle PS; McKerrow JH; Ellman JA
    J Am Chem Soc; 2008 May; 130(20):6404-10. PubMed ID: 18435536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease.
    Siles R; Chen SE; Zhou M; Pinney KG; Trawick ML
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4405-9. PubMed ID: 16781147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly predictive hologram QSAR models of nitrile-containing cruzain inhibitors.
    Silva DG; Rocha JR; Sartori GR; Montanari CA
    J Biomol Struct Dyn; 2017 Nov; 35(15):3232-3249. PubMed ID: 27809673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of chagasin, the endogenous cysteine-protease inhibitor from Trypanosoma cruzi.
    Figueiredo da Silva AA; de Carvalho Vieira L; Krieger MA; Goldenberg S; Zanchin NI; Guimarães BG
    J Struct Biol; 2007 Feb; 157(2):416-23. PubMed ID: 17011790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study.
    Vital DG; Damasceno FS; Rapado LN; Silber AM; Vilella FS; Ferreira RS; Maltarollo VG; Trossini GH
    J Biomol Struct Dyn; 2017 May; 35(6):1244-1259. PubMed ID: 27064715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
    Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
    Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening.
    Li H; Huang J; Chen L; Liu X; Chen T; Zhu J; Lu W; Shen X; Li J; Hilgenfeld R; Jiang H
    J Med Chem; 2009 Aug; 52(15):4936-40. PubMed ID: 19586036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases.
    Eurtivong C; Zimmer C; Schirmeister T; Butkinaree C; Saruengkhanphasit R; Niwetmarin W; Ruchirawat S; Bhambra AS
    Mol Divers; 2024 Apr; 28(2):531-551. PubMed ID: 36617352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors.
    Ehmke V; Quinsaat JE; Rivera-Fuentes P; Heindl C; Freymond C; Rottmann M; Brun R; Schirmeister T; Diederich F
    Org Biomol Chem; 2012 Aug; 10(30):5764-8. PubMed ID: 22336919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.
    Desai PV; Patny A; Sabnis Y; Tekwani B; Gut J; Rosenthal P; Srivastava A; Avery M
    J Med Chem; 2004 Dec; 47(26):6609-15. PubMed ID: 15588096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors.
    Burtoloso AC; de Albuquerque S; Furber M; Gomes JC; Gonçalez C; Kenny PW; Leitão A; Montanari CA; Quilles JC; Ribeiro JF; Rocha JR
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005343. PubMed ID: 28222138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling.
    Yadav MK; Singh A; Swati D
    Appl Biochem Biotechnol; 2014 Aug; 173(8):2174-88. PubMed ID: 24970047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach.
    de Souza ML; de Oliveira Rezende Junior C; Ferreira RS; Espinoza Chávez RM; Ferreira LLG; Slafer BW; Magalhães LG; Krogh R; Oliva G; Cruz FC; Dias LC; Andricopulo AD
    J Chem Inf Model; 2020 Feb; 60(2):1028-1041. PubMed ID: 31765144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.